Join Free For Buyer|Sign In

Professional Online Trade Platform for API, Preparation and Pharmaceutical Machinery and Equipment_EN-CPhI.cn

You are here:  Home >>  News >>  Editors’ Picks >>  New Edition of China’s National Essential Drugs List Has Released!

New Edition of China’s National Essential Drugs List Has Released!

November 07, 2018 By Xiaoyu

New Edition of China’s National Essential Drugs List Released:

Types of Insulin and Oral Hypoglycemic Drug Increased by 150%, with Varieties being Newer and More Complete!

New Edition of China’s National Essential Drugs List Released!

National Essential Drugs List

--2018 Edition--

Type

2012 edition

2018 edition

Variety name

Dosage form, specification

Variety name

Dosage form, specification

Insulin

Insulin

Animal-sourced insulin injection (short-acting, intermediate-acting, long-acting, and premixed): 400 units

Recombinant human insulin injection (short-acting, intermediate-acting, and premixed 30R): 300 units, 400 units

Insulin

Animal-sourced insulin injection (short-acting, intermediate-acting, long-acting, and premixed): 300 units, 400 units

Recombinant human insulin injection (short-acting, intermediate-acting, and premixed 30R): 300 units, 400 units

 

 

 

Insulin Glargine

Injection: 3ml:300 units (prefilled), 3ml:300 units (refill)

Non-insulin secretagogue

Thiazolidinedione (glitazone)

 

 

Pioglitazone

Tablet: 15mg, 30mg

Capsule: 15mg, 30mg

Biguanide

Metformin

Tablet, enteric-coated (tablet, capsule), sustained-release tablet: 0.25g, 0.5g

Capsule: 0.25g

Metformin

Tablet, enteric-coated (tablet, capsule), sustained-release tablet: 0.25g, 0.5g

Capsule: 0.25g

Sustained-release capsule: 0.25g

SGLT-2 inhibitor

 

 

Dapagliflozin

Tablet: 5mg, 10mg

Alpha-glucosidase inhibitor

Acarbose

Tablet, capsule: 50mg

Acarbose

Tablet, capsule: 50mg

Type

2012 edition

2018 edition

Variety name

Dosage form, specification

Variety name

Dosage form, specification

Incretin

GLP-1 receptor agonist

 

 

Liraglutide

Injection: 3ml:18mg

DPP-4 inhibitor

 

 

Sitagliptin

Tablet: 25mg, 50mg, 100mg

 

 

 

Linagliptin

Tablet: 5mg

Insulin secretagogue

Sulfonylurea

 

Glibenclamide

Tablet: 2.5mg

Glibenclamide

Tablet: 2.5mg

Glipizide

Tablet, capsule: 5mg

Glipizide

Tablet, capsule: 5mg

Glimepiride

Tablet: 1mg, 2mg

Glimepiride

Tablet: 1mg, 2mg

 

 

Gliquidone

Tablet: 30mg

 

 

Gliclazide

Tablet (II): 80mg

Non-sulfonylurea (glinide)

 

 

Repaglinide

Tablet: 0.5mg, 1mg, 2mg

-----------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.

 

Readers'Comments
Add a comment
Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.
More>> MarketNews
More>> Editors’Picks
More>> TopStories
More>> HotTags
Follow Us
CPhI Online Trade Platform: Worldwide|English|中国站
Customer Service:  86-400 610 1188 (9: 00-18: 00, Mon-Fri)
About Us| Contact Us| Terms of Services| Privacy Policy| Intellectual Property Statement| Links | Site Map
Copyright 2006-20 Shanghai UBM Sinoexpo International Exhibition Co Ltd (All Rights Reserved). ICP 05034851-53
网页对话
live chat